Patents Assigned to Debio Recherche Pharmaceutique S.A.
-
Patent number: 8501683Abstract: At least one embodiment of the present invention relates to new cycloundecadepsipeptide compounds and to the use of said compounds as a medicament, in particular as antiviral agents, more particularly for preventing or treating Hepatitis C infections or HCV induced disorders.Type: GrantFiled: November 6, 2009Date of Patent: August 6, 2013Assignee: Debio Recherche Pharmaceutique S.A.Inventors: Roland Wenger, Manfred Mutter, Patrick Garrouste, Robert Lysek, Olivier Turpin, Grégoire Vuagniaux, Valérie Nicolas, Laura Novaroli Zanolari, Rafael Crabbé
-
Publication number: 20110212057Abstract: At least one embodiment of the present invention relates to new cycloundecadepsipeptide compounds and to the use of said compounds as a medicament, in particular as antiviral agents, more particularly for preventing or treating Hepatitis C infections or HCV induced disorders.Type: ApplicationFiled: November 6, 2009Publication date: September 1, 2011Applicant: Debio Recherche Pharmaceutique S.A.Inventors: Roland Wenger, Manfred Mutter, Patrick Garrouste, Robert Lysex, Olivier Turpin, Grégoire Vuagniaux, Valérie Nicolas, Laura Novaroli Zanolari, Rafael Crabbé
-
Patent number: 7214388Abstract: A heterobifunctional poly(ethylene glycol) is provided having a hydrolytically degradable linkage, a first terminus comprising an acrylate group, and a second terminus comprising a target such as a protein or pharmaceutical agent or a reactive moiety capable of coupling to a target. Hydrogels can be prepared. The hydrogels can be used as a carrier for a protein or a pharmaceutical agent that can be readily released in a controlled fashion.Type: GrantFiled: October 14, 2003Date of Patent: May 8, 2007Assignee: Debio Recherche Pharmaceutique S.A.Inventors: J. Milton Harris, Xuan Zhao
-
Patent number: 7166304Abstract: A heterobifunctional poly(ethylene glycol) is provided having a hydrolytically degradable linkage, a first terminus comprising an acrylate group, and a second terminus comprising a target such as a protein or pharmaceutical agent or a reactive moiety capable of coupling to a target. Hydrogels can be prepared. The hydrogels can be used as a carrier for a protein or a pharmaceutical agent that can be readily released in a controlled fashion.Type: GrantFiled: October 14, 2003Date of Patent: January 23, 2007Assignee: Debio Recherche Pharmaceutique S.A.Inventors: J. Milton Harris, Xuan Zhao
-
Patent number: 7018624Abstract: A degradable PEG hydrogel is described that, upon hydrolysis, releases conjugates of substantially non-peptidic polymers and biologically active molecules. For example, PEG and protein conjugates can be released in vivo from the hydrogels for therapeutic application.Type: GrantFiled: March 14, 2003Date of Patent: March 28, 2006Assignee: Debio Recherche Pharmaceutique S.A.Inventor: J. Milton Harris
-
Patent number: 6777002Abstract: The present invention relates to a process for the preparation of microparticles, with an extremely high encapsulation rate, comprising a water-soluble substance in a biodegradable polymer, said water-soluble substance and said biodegradable polymer being first incorporated in an organic liquid phase comprising at least one organic non-water miscible solvent. The organic phase is poured into an aqueous liquid phase having a volume which is sufficient to dissolve said organic solvent, said aqueous phase containing a surfactant, the resulting organic-aqueous phase being homogenised in order to perform in one single step the microparticle formation and the organic solvent removal. The thus obtained microparticles show surprisingly good agent retention qualities.Type: GrantFiled: October 15, 2001Date of Patent: August 17, 2004Assignee: Debio Recherche Pharmaceutique S.A.Inventors: Evelyne Vuaridel, Piero Orsolini
-
Publication number: 20040086991Abstract: A heterobifunctional poly(ethylene glycol) is provided having a hydrolytically degradable linkage, a first terminus comprising an acrylate group, and a second terminus comprising a target such as a protein or pharmaceutical agent or a reactive moiety capable of coupling to a target. Hydrogels can be prepared. The hydrogels can be used as a carrier for a protein or a pharmaceutical agent that can be readily released in a controlled fashion.Type: ApplicationFiled: October 14, 2003Publication date: May 6, 2004Applicant: Debio Recherche Pharmaceutique S.A.Inventors: J. Milton Harris, Xuan Zhao
-
Publication number: 20040086992Abstract: A heterobifunctional poly(ethylene glycol) is provided having a hydrolytically degradable linkage, a first terminus comprising an acrylate group, and a second terminus comprising a target such as a protein or pharmaceutical agent or a reactive moiety capable of coupling to a target. Hydrogels can be prepared. The hydrogels can be used as a carrier for a protein or a pharmaceutical agent that can be readily released in a controlled fashion.Type: ApplicationFiled: October 14, 2003Publication date: May 6, 2004Applicant: Debio Recherche Pharmaceutique S.A.Inventors: J. Milton Harris, Xuan Zhao
-
Publication number: 20040076602Abstract: This invention relates to hydrolytically degradable gels of crosslinked poly(ethylene) glycol (PEG) structures. Addition of water causes these crosslinked structures to swell and become hydrogels. The hydrogels can be prepared by reacting two different PEG derivatives containing functional moietes at the chain ends that react with each other to form new covalent linkages between polymer chains. The PEG derivatives are chosen to provide covalent linkages within the crosslinked structure that are hydrolytically degradable. Hydrolytic degradation can provide for dissolution of the gel components and for controlled release of trapped molecules, including drugs. Reageants other than PEG can be avoided. The hydrolysis rates can be controlled by varying atoms adjacent to the hydrolytically degradable functional groups to provide substantially precise control for drug delivery in vivo.Type: ApplicationFiled: October 14, 2003Publication date: April 22, 2004Applicant: Debio Recherche Pharmaceutique S.A.Inventor: J. Milton Harris
-
Publication number: 20030202955Abstract: A degradable PEG hydrogel is described that, upon hydrolysis, releases conjugates of substantially non-peptidic polymers and biologically active molecules. For example, PEG and protein conjugates can be released in vivo from the hydrogels for therapeutic application.Type: ApplicationFiled: March 14, 2003Publication date: October 30, 2003Applicant: Debio Recherche Pharmaceutique S.A.Inventor: J. Milton Harris
-
Patent number: 6558658Abstract: A degradable PEG hydrogel is described that, upon hydrolysis, releases conjugates of substantially non-peptidic polymers and biologically active molecules. For example, PEG and protein conjugates can be released in vivo from the hydrogels for therapeutic application.Type: GrantFiled: April 2, 2001Date of Patent: May 6, 2003Assignee: Debio Recherche Pharmaceutique S.A.Inventor: J. Milton Harris
-
Patent number: 6432397Abstract: A degradable PEG hydrogel is described that, upon hydrolysis, releases conjugates of substantially non-peptidic polymers and biologically active molecules. For example, PEG and protein conjugates can be released in vivo from the hydrogels for therapeutic application.Type: GrantFiled: October 25, 1999Date of Patent: August 13, 2002Assignee: Debio Recherche Pharmaceutique S. A.Inventor: J. Milton Harris
-
Patent number: 6362276Abstract: A heterobifunctional poly(ethylene glycol) is provided having a hydrolytically degradable linkage, a first terminus comprising an acrylate group, and a second terminus comprising a target such as a protein or pharmaceutical agent or a reactive moiety capable of coupling to a target. Hydrogels can be prepared. The hydrogels can be used as a carrier for a protein or a pharmaceutical agent that can be readily released in a controlled fashion.Type: GrantFiled: January 6, 1999Date of Patent: March 26, 2002Assignee: Debio Recherche Pharmaceutique S.A.Inventors: J. Milton Harris, Xuan Zhao
-
Publication number: 20020032281Abstract: A degradable PEG hydrogel is described that, upon hydrolysis, releases conjugates of substantially non-peptidic polymers and biologically active molecules. For example, PEG and protein conjugates can be released in vivo from the hydrogels for therapeutic application.Type: ApplicationFiled: April 2, 2001Publication date: March 14, 2002Applicant: Debio Recherche Pharmaceutique S.A.Inventor: J. Milton Harris
-
Publication number: 20010016624Abstract: A heterobifunctional poly(ethylene glycol) is provided having a hydrolytically degradable linkage, a first terminus comprising an acrylate group, and a second terminus comprising a target such as a protein or pharmaceutical agent or a reactive moiety capable of coupling to a target. Hydrogels can be prepared. The hydrogels can be used as a carrier for a protein or a pharmaceutical agent that can be readily released in a controlled fashion.Type: ApplicationFiled: April 2, 2001Publication date: August 23, 2001Applicant: Debio Recherche Pharmaceutique S.A.Inventors: J. Milton Harris, Xuan Zhao
-
Patent number: 6245346Abstract: Pharmaceutical composition for the controlled release of at least one water-insoluble active principle, containing a homopolymer of D,L-lactic acid or of L-lactic acid of low molecular weight combined with said active principle, wherein the molecular weight of the homopolymer of D,L-lactic acid is between approximately 2,000 and 6,000 daltons or the molecular weight of the homopolymer of L-lactic acid is about 4,000 daltons.Type: GrantFiled: January 6, 1999Date of Patent: June 12, 2001Assignee: Debio Recherche Pharmaceutique S.A.Inventors: Alexandra Rothen-Weinhold, Robert Gurny, Piero Orsolini, Frédéric Heimgartner
-
Patent number: 5445832Abstract: The process is aimed at providing a composition designed for the sustained and controlled release of medicamentous peptide substances, obtained in the form of microspheres of a biodegradable polymeric material incorporating said medicamentous substance.It consists in converting first a water-soluble peptide or peptide salt into a water-insoluble peptide, respectively peptide salt. The following steps include preparing an organic-aqueous emulsion and then extracting the organic solvent in an excess of aqueous medium.Type: GrantFiled: July 16, 1992Date of Patent: August 29, 1995Assignee: Debio Recherche Pharmaceutique S.A.Inventors: Piero Orsolini, Frederic Heimgartner
-
Patent number: 5439688Abstract: A pharmaceutical composition is prepared in the form of microparticles or of an implant comprising a biodegradable polymer selected from poly-1,4-butylene succinate, poly-2,3-butylene succinate, poly-1,4-butylene fumarate and poly-2,3-butylene succinate, incorporating as the active substance the pamoate, tannate, stearate or palmitate of a natural or of a synthetic peptide comprising 3 to 45 amino acids, such as LH-RH, somatostatin, GH-RH or calcitonin, or one of their synthetic analogues or homologues. The preparation comprises dry blending the ingredients in the form of powders, pre-compressing and preheating the mixture and then extruding the pre-compressed and pre-heated mixture. The product resulting from the extrusion step can then be comminuted and finally sieved.Type: GrantFiled: November 12, 1991Date of Patent: August 8, 1995Assignee: Debio Recherche Pharmaceutique S.A.Inventors: Piero Orsolini, Frederic Heimgartner